Clinical Trial Detail

NCT ID NCT01540682
Title MLN8237 in Head and Neck Cancer
Recruitment Completed
Gender
Phase
Variant Requirements No
Sponsors
Indications
Therapies

Cetuximab

Age Groups:

No variant requirements are available.